Syros Pharmaceuticals (NASDAQ:SYRS) Coverage Initiated at StockNews.com
Equities research analysts at StockNews.com initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating on the stock. SYRS has been the subject of a number of other research reports. TD Cowen reissued a “hold” rating on shares of Syros […]
Equities research analysts at StockNews.com initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating on the stock. SYRS has been the subject of a number of other research reports. TD Cowen reissued a “hold” rating on shares of Syros […]
